BETHLEHEM, Pa. -- B. Braun Medical Inc. announced today
it has received U.S. FDA clearance for the use of its Ultrasite Needle-Free
IV System with power injectors up to 300 psi, helping to prevent exposure
to dangerous bloodborne pathogens in the radiology suite. B. Braun is the
first and only company to receive FDA 510(k) clearance for needle-free IV
system use with power injectors.
As a result of sharps injuries, 2,000 workers a year become infected
with hepatitis C, 400 contract hepatitis B, and more than 36 U.S.
healthcare workers a year contract HIV. According to the Society of
Interventional Radiology, self-sheathing or needleless intravenous systems
should be used whenever possible to prevent exposure to bloodborne pathogens
in vascular/interventional radiology.
The Ultrasite Needle-Free IV System is designed to eliminate the risk of
accidental needlestick injuries. Ultrasite features patented technology
that virtually assures compliance by preventing needle access. This highly
effective passive engineering control protects both patients and caregivers.
The Ultrasite is a patented valve with a positive displacement design that
uses an internal plunger to expel fluid when the Luer taper is removed,
preventing blood from being drawn back into the IV system. In addition, its
design offers exceptional flow rates while enabling it to be used across a
variety of IV therapy applications.
"The Needlestick Safety and Prevention Act (NSPA) requires all U.S.
healthcare facilities to implement safer needle devices," said Gregory S.
Jones, director of IV systems at B. Braun Medical Inc. "The Ultraasite Needle-Free
IV System is designed to eliminate the risk of accidental needlestick injury
and support these safety compliance initiatives. We are pleased to
announce that we can now offer this cornerstone product in our "People,
Products and Programs" safety initiative to protect clinicians in the
radiology suite."
With more than 28,000 employees worldwide, B. Braun is a full line supplier
of innovative healthcare products and programs designed to improve both
patient and clinician safety.
Source: B. Braun
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.